BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//College on Problems of Drug Dependence - CPDD - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://cpdd.org
X-WR-CALDESC:Events for College on Problems of Drug Dependence - CPDD
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240309T080000
DTEND;TZID=America/New_York:20240310T170000
DTSTAMP:20260405T111038
CREATED:20230831T164035Z
LAST-MODIFIED:20230831T164035Z
UID:12145-1709971200-1710090000@cpdd.org
SUMMARY:ASCP 2024 Spring Virtual Meeting
DESCRIPTION:
URL:https://cpdd.org/event/ascp-2024-spring-virtual-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240411T080000
DTEND;TZID=America/New_York:20240414T170000
DTSTAMP:20260405T111038
CREATED:20230829T205301Z
LAST-MODIFIED:20230829T205301Z
UID:12119-1712822400-1713114000@cpdd.org
SUMMARY:ADAA 2024 Annual Conference for Cross Promotion
DESCRIPTION:  \n  \nMeeting Website:  ADAA 2024 Anxiety and Depression Conference
URL:https://cpdd.org/event/adaa-2024-annual-conference-for-cross-promotion/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240416T123000
DTEND;TZID=America/New_York:20240416T133000
DTSTAMP:20260405T111038
CREATED:20240214T204415Z
LAST-MODIFIED:20240214T204415Z
UID:13194-1713270600-1713274200@cpdd.org
SUMMARY:NABR Webinar: “One Health and Animal Research: The Good\, the Bad\, and the Ugly”
DESCRIPTION:NABR Webinar:“One Health and Animal Research: The Good\, the Bad\, and the Ugly” \nPlease join us on Tuesday\, April 16th\, at 12:30 p.m. EST when Jerrold Tannenbaum returns to our webinar series with a presentation titled: “One Health and Animal Research: The Good\, the Bad\, and the Ugly.” “One Health” is today the most influential organizing concept in the medical sciences. From the American Veterinary Medical Association\, to the American Medical Association\, to the World Health Organization\, One Health is proclaimed — and virtually universally accepted — as both the primary goal of\, and the underlying methodological approach used in medical and veterinary research\, education\, and practice. \nThis webinar will describe the crucial role laboratory animal research played in the development of the concept of One Medicine\, the historical precursor of One Health. The discussion will review differing approaches to One Health and will discuss how biomedical animal research can be an important component of some of these approaches. The webinar will also highlight current approaches to One Health that provide challenges to laboratory animal research. These include the increasing use of privately owned animals\, mainly pet cats and dogs\, in clinical studies and trials. Of greater concern are approaches to One Health that diminish the importance of human and animal research that benefits human health; would require the diversion of critical resources away from animal research; incorporate concepts of “health” (such as environmental health\, ecosystem health\, or planetary health) that are unhelpful and may be incoherent; and include societal or geopolitical considerations that have no clear connection to science-driven biomedical research. \nThe webinar will examine how the biomedical research community can recognize\, and counter approaches to One Health that are inimical to or threaten animal research. The discussion will suggest ways the community can support and engage in approaches to One Health that appropriately benefit people\, animals\, and the environment. \nRegistration for the webinar is available here. \n​​​​​​
URL:https://cpdd.org/event/nabr-webinar-one-health-and-animal-research-the-good-the-bad-and-the-ugly/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240416T123000
DTEND;TZID=America/New_York:20240416T133000
DTSTAMP:20260405T111038
CREATED:20240405T205655Z
LAST-MODIFIED:20240405T205655Z
UID:13360-1713270600-1713274200@cpdd.org
SUMMARY:NABR Webinar: “One Health and Animal Research: The Good\, the Bad\, and the Ugly”
DESCRIPTION:NABR Webinar:“One Health and Animal Research: The Good\, the Bad\, and the Ugly” \nPlease join us on Tuesday\, April 16th\, at 12:30 p.m. EST when Jerrold Tannenbaum returns to our webinar series with a presentation titled: “One Health and Animal Research: The Good\, the Bad\, and the Ugly.” “One Health” is today the most influential organizing concept in the medical sciences. From the American Veterinary Medical Association\, to the American Medical Association\, to the World Health Organization\, One Health is proclaimed — and virtually universally accepted — as both the primary goal of\, and the underlying methodological approach used in medical and veterinary research\, education\, and practice. \nThis webinar will describe the crucial role laboratory animal research played in the development of the concept of One Medicine\, the historical precursor of One Health. The discussion will review differing approaches to One Health and will discuss how biomedical animal research can be an important component of some of these approaches. The webinar will also highlight current approaches to One Health that provide challenges to laboratory animal research. These include the increasing use of privately owned animals\, mainly pet cats and dogs\, in clinical studies and trials. Of greater concern are approaches to One Health that diminish the importance of human and animal research that benefits human health; would require the diversion of critical resources away from animal research; incorporate concepts of “health” (such as environmental health\, ecosystem health\, or planetary health) that are unhelpful and may be incoherent; and include societal or geopolitical considerations that have no clear connection to science-driven biomedical research. \nThe webinar will examine how the biomedical research community can recognize\, and counter approaches to One Health that are inimical to or threaten animal research. The discussion will suggest ways the community can support and engage in approaches to One Health that appropriately benefit people\, animals\, and the environment. \nRegistration for the webinar is available here. \n​​​​​​
URL:https://cpdd.org/event/nabr-webinar-one-health-and-animal-research-the-good-the-bad-and-the-ugly-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240423T080000
DTEND;TZID=America/New_York:20240423T170000
DTSTAMP:20260405T111038
CREATED:20231201T205947Z
LAST-MODIFIED:20231201T205947Z
UID:13023-1713859200-1713891600@cpdd.org
SUMMARY:6th Annual Substance Use Research Event
DESCRIPTION:
URL:https://cpdd.org/event/6th-annual-substance-use-research-event/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240617T080000
DTEND;TZID=America/New_York:20240618T170000
DTSTAMP:20260405T111038
CREATED:20231206T185236Z
LAST-MODIFIED:20231206T185236Z
UID:13053-1718611200-1718730000@cpdd.org
SUMMARY:ESLAV-ECLAM-AAALAC Conference\, 17-18 June 2024
DESCRIPTION:Save The Date! \nConference website: https://eslav-eclam-aaalac-conference2024.eu/en/welcome/The joint ESLAV-ECLAM-AAALAC Conference will be held on 17-18 June 2024 in Amsterdam. The conference will be followed by the ESLAV-ECLAM Summer School\, 19-21 June\, also in Amsterdam. Additional details on the conference venue\, exhibiting\, abstracts and more will be shared on the conference website.
URL:https://cpdd.org/event/eslav-eclam-aaalac-conference-17-18-june-2024/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240619T080000
DTEND;TZID=America/New_York:20240621T170000
DTSTAMP:20260405T111038
CREATED:20240318T163840Z
LAST-MODIFIED:20240318T163840Z
UID:13287-1718784000-1718989200@cpdd.org
SUMMARY:ISSDP 2024 Conference
DESCRIPTION:
URL:https://cpdd.org/event/issdp-2024-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240716T123000
DTEND;TZID=America/New_York:20240716T133000
DTSTAMP:20260405T111038
CREATED:20240529T161038Z
LAST-MODIFIED:20240529T161038Z
UID:13492-1721133000-1721136600@cpdd.org
SUMMARY:NABR Webinar: Q&A With the USDA - The 12th Edition
DESCRIPTION:NABR Webinar: Q&A With the USDA - The 12th Edition \nNABR is once again pleased to announce the return of one of its most requested webinars\,  "Q&A with the USDA." Join USDA-APHIS Animal Care’s Drs. Elizabeth Theodorson\, assistant deputy administrator for Animal Welfare Operations\, and Dr. Louis DiVincenti\, senior veterinary medical officer -research\, for "Q&A with the USDA: The 12th Edition” on Tuesday\, July 16 at 12:30 p.m. EDST. \nAs in the past this webinar will provide NABR members with a unique opportunity to ask questions directly of the leadership of Animal Care’s Animal Welfare Operations. A lot has changed in the last year. The final rule on Standards for Birds Not Bred for Use in Research Under the Animal Welfare Act was implemented\, the Animal Welfare Inspection Guide was revised\, and the USDA and Justice Department entered into a Memorandum of Understanding on Civil Enforcement of the Animal Welfare Act. You should take advantage of this unique opportunity provided to NABR members to better understand what impact these and other ongoing changes may have on your institution concerning compliance with the Animal Welfare Regulations. \nQuestions should be submitted in advance to info@nabr.org. They will be reviewed and formatted to prevent duplication and will be answered in the order they are received\, so please submit them as soon as possible. As in the past we will schedule the session for an hour but will continue the webinar until all questions have been addressed. \nRegistration is available here. \n​​​​​​
URL:https://cpdd.org/event/nabr-webinar-qa-with-the-usda-the-12th-edition/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240723T130000
DTEND;TZID=America/New_York:20240723T140000
DTSTAMP:20260405T111038
CREATED:20240715T144054Z
LAST-MODIFIED:20240717T123643Z
UID:13530-1721739600-1721743200@cpdd.org
SUMMARY:Introduction to FDA’s Office of Trade and Global Partnerships
DESCRIPTION:Introduction to FDA’s Office of Trade and Global Partnerships \nJuly 23\, 2024 – Webinar\nIntroduction to FDA’s Office of Trade and Global Partnerships \nLearn about the FDA’s Office of Trade and Global Partnerships (OTGP) and how its work relates to pharmaceutical products. This discussion will also cover the different types of international agreements and arrangements used by the FDA. \n\n\n\nLinkedIn: SBIA|Webinar: July 23\, 2024 – Introduction to FDA’s Office of Trade and Global Partnerships\nX: SBIA|Webinar: July 23\, 2024 – Introduction to FDA’s Office of Trade and Global Partnerships
URL:https://cpdd.org/event/introduction-to-fdas-office-of-trade-and-global-partnerships/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240730T140000
DTEND;TZID=America/New_York:20240730T150000
DTSTAMP:20260405T111038
CREATED:20240715T144226Z
LAST-MODIFIED:20240715T144226Z
UID:13531-1722348000-1722351600@cpdd.org
SUMMARY:Environmental Monitoring in Compounding
DESCRIPTION:Environmental Monitoring in Compounding \nJuly 30\, 2024 – Webinar\nEnvironmental Monitoring in Compounding \nGet an overview of environmental monitoring for compounding facilities and the role it plays in ensuring product quality and patient safety. Presenters will discuss statutory and regulatory requirements\, expectations for compounding pharmacies and outsourcing facilities\, and different methods specific to environmental monitoring. \n\n\n\nLinkedIn: SBIA|Webinar: July 30\, 2024 – Environmental Monitoring in Compounding\nX: SBIA|Webinar: July 30\, 2024 – Environmental Monitoring in Compounding
URL:https://cpdd.org/event/environmental-monitoring-in-compounding/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240911T130000
DTEND;TZID=America/New_York:20240911T140000
DTSTAMP:20260405T111038
CREATED:20240903T144036Z
LAST-MODIFIED:20240903T144036Z
UID:13616-1726059600-1726063200@cpdd.org
SUMMARY:Next National Advisory Council on Drug Abuse Meeting: September 11
DESCRIPTION:Next National Advisory Council on Drug Abuse Meeting: September 11 \nThe National Advisory Council on Drug Abuse (NACDA) serves a crucial role in advising NIDA\, and\, by extension\, the Director\, NIH and the Secretary\, DHHS\, as NIDA identifies\, reviews\, and supports the highest caliber of scientific research. \nThe next NACDA meeting will take place Wednesday\, September 11\, 2024. Additional details and a link to the videocast are available here. \n\n\n\n\n\n\n\nJoin the Videocast on Sept. 11
URL:https://cpdd.org/event/next-national-advisory-council-on-drug-abuse-meeting-september-11/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240912T083000
DTEND;TZID=America/New_York:20240912T180000
DTSTAMP:20260405T111038
CREATED:20240715T144528Z
LAST-MODIFIED:20240715T144528Z
UID:13532-1726129800-1726164000@cpdd.org
SUMMARY:Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024
DESCRIPTION:Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024 \nSeptember 12\, 2024 ­– Webinar\n8:45 am-5:45pm \nElectronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024 \nThis demonstration of how to submit establishment registration and drug listing data using CDER Direct will feature case studies for an interactive learning experience. \n\n\n\nLinkedIn: SBIA|Webinar: September 12\, 2024 – Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024\nX: SBIA|Webinar: September 12\, 2024 – Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024
URL:https://cpdd.org/event/electronic-drug-registration-and-listing-edrls-using-cder-direct-2024/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240927T130000
DTEND;TZID=America/Los_Angeles:20240927T163000
DTSTAMP:20260405T111038
CREATED:20240924T201352Z
LAST-MODIFIED:20240924T201404Z
UID:13665-1727442000-1727454600@cpdd.org
SUMMARY:Sex Differences in Addiction Workshop
DESCRIPTION:Sex Differences in Addiction Workshop  \nOrganized in conjunction with ACU’s Healthy Brain and Mind Research Centre\, experts from the National Institute on Drug Abuse\, and the ENIGMA consortium \nWhen: Friday 27 September 2024 (1pm – 4.30pm PDT\, see other timezones)\nWhere: Online via Zoom\nRegistration: https://forms.gle/LxCPPCPUVtpHL24n9\nFind more info at: https://enigma.ini.usc.edu/events/upcoming-events/ \nErynn\, on behalf of the Sex Differences in Addiction Organising Committee:  Isabella Goodwin\, ACU; Dr Erynn Christensen\, Feinstein Institutes for Medical Research; Dr Sophia Thomopoulos\, University of Southern California; Prof Rita Valentino\, NIDA; & A/Prof Valentina Lorenzetti\, ACU (Chair) 
URL:https://cpdd.org/event/sex-differences-in-addiction-workshop/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241008T123000
DTEND;TZID=America/New_York:20241008T133000
DTSTAMP:20260405T111038
CREATED:20240814T144054Z
LAST-MODIFIED:20240814T144054Z
UID:13587-1728390600-1728394200@cpdd.org
SUMMARY:NABR Webinar: “Current and Future Challenges Facing Biomedical Research”
DESCRIPTION:NABR Webinar: “Current and Future Challenges Facing Biomedical Research” \nPlease join us on Tuesday\, Oct. 8\, at 12:30 p.m. EST for the 61st NABR webinar when Matt Bailey\, President of NABR and FBR; Brandon Morton\, NABR’s Director of Government Affairs; and Taylor Bennett\, NABR’s Senior Scientific Advisor\, sit down to discuss the “Current and Future Challenges Facing Biomedical Research.” NABR is the only national nonprofit organization dedicated solely to advocating for sound public policy that recognizes the vital role animals play in biomedical research. In that role\, NABR provides the unified voice for the scientific community on legislative and regulatory matters affecting laboratory animal research at the federal level. FBR provides valuable communication expertise promoting public understanding and support for biomedical research to address the challenges and variety of tactics used by those opposed to animals in biomedical research. These tactics include calling into question the validity of animal models\, the money spent to support that research\, an increased number of legislative efforts at the federal\, state and local level and targeted campaigns against specific areas of research. In addition\, these groups have effectively weaponized the use of FOIA and state open records acts to target institutions and individuals. In this webinar\, recent legislative and regulatory issues will be reviewed\, and animal rights campaigns will be highlighted to share lessons learned for addressing the challenges facing the research community. \nRegister:  https://register.gotowebinar.com/register/1681185605630712411 
URL:https://cpdd.org/event/nabr-webinar-current-and-future-challenges-facing-biomedical-research/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241015T080000
DTEND;TZID=America/New_York:20241016T170000
DTSTAMP:20260405T111038
CREATED:20241014T212216Z
LAST-MODIFIED:20241014T212216Z
UID:13723-1728979200-1729098000@cpdd.org
SUMMARY:Professional NIH Grant Development Live Online Workshop
DESCRIPTION:Professional NIH Grant Development Live Online Workshop\nOctober 15-16\, 2024\n10:30 a.m. to 6:00 p.m. Eastern Time\nSponsored by the Grant Training Center \nThe Professional NIH Grant Development live online workshop\, which is normally held at the University of Pennsylvania\, has moved online. It will include the same content and length of instruction. \nYou will learn how to: \n\nMake the match with the appropriate NIH institute\, program and grant mechanism\nIdentify and avoid common pitfalls of a grant\nWrite exceptional Specific Aims pages\nEffectively address each piece of the application\nUnderstand the review process and successfully write for reviewers\nComprehend what happens in the study section\nDecipher pink sheets: The inevitable resubmission\nBuild an airtight case for funding\n\nOur ultimate goal is for you to walk away with a product specific to your interests. \nRegister  \nWorkshop Fee: $595.00\nIncludes a comprehensive list of resources\, workbook\, and certificate of completion \nRebate of $45.00 per person\nFor two or more registrants from the same organization \nCan't make this session?\nSelf-paced NIH course\nto fit any schedule \nFollow-up workshop on dissecting full proposals through expert feedback enhances chances of success\nReviewing and Refining Your NIH Proposal\nOctober 17\, 2024 \nSince this class fills up quickly\, it is on a first-come\, first serve basis \nRegister for our membership and a workshop and receive a $50 rebate. Only the highest discount will apply. \nQuestions? Call (866) 704-7268.
URL:https://cpdd.org/event/professional-nih-grant-development-live-online-workshop/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241018
DTEND;VALUE=DATE:20241024
DTSTAMP:20260405T111038
CREATED:20240715T151322Z
LAST-MODIFIED:20240715T151412Z
UID:13533-1729209600-1729727999@cpdd.org
SUMMARY:NAADAC 2024 Annual Conference & Hill Day
DESCRIPTION:FROM THE NAADAC WEBSITE: \nRegistration Information for the NAADAC 2024 Annual Conference & Hill Day \n \nJoin us for the NAADAC 2024 Annual Conference & Hill Day: Learn\, Connect\, Advocate\, Succeed\, in the Washington\, DC\, area at the Gaylord National Resort & Convention Center from October 18 - 23\, 2024. \nThis year's conference will feature dozens of educational sessions presented by nationally recognized speakers\, an exhibit hall\, networking opportunities\, and so much more! Register now! \nThree-Day Conference Registration   |  One-Day Registration   |   Special Events Registration   |   Registration Cancellation Policy    |   Pre-Conference Registration    |   Post-Conference Registration \n 
URL:https://cpdd.org/event/naadac-2024-annual-conference-hill-day/
LOCATION:Washington DC
CATEGORIES:Other Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241021T090000
DTEND;TZID=America/New_York:20241021T163000
DTSTAMP:20260405T111038
CREATED:20240924T134222Z
LAST-MODIFIED:20240924T134222Z
UID:13658-1729501200-1729528200@cpdd.org
SUMMARY:FDA and NIH Joint Public Meeting on Advancing Smoking Cessation Priorities
DESCRIPTION:FDA and NIH Joint Public Meeting on Advancing Smoking Cessation Priorities\nREGISTRATION IS OPEN \nOn Monday\, October 21\, from 9 a.m. to 4:30 p.m. EDT\, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will host a joint public meeting entitled\, “Advancing Smoking Cessation: FDA and NIH Priorities.” The focus of the meeting is on advancing innovation of smoking cessation products to help both adults and youth. \nThe meeting will feature presentations and panel discussions on several smoking cessation-focused topics\, including:\n• Clinical and community perspectives\n• Promising target areas for development\n• Regulatory paths forward \nThe meeting will include an opportunity for public comment on several topics related to cessation. \nThe meeting is free\, and can be attended virtually or in-person at the FDA’s White Oak campus in Silver Spring\, Maryland. Additional information about the meeting\, including specific questions for which public comment is being sought\, is found in the Federal Register notice announcing the meeting. Deadlines for registration\, including for public comment\, are as follows:\n• In-person registration is required by October 15\, 2024\, while virtual registration is open through 9:00 a.m. EDT on the day of the meeting.\n• Registration to speak in-person during the public comment portion of the meeting is required by October 1 at 5:00 p.m. EDT. Please note that public comments during the meeting will only be accepted in person and not virtually. Every effort will be made to accommodate as many speakers as possible; however\, speaking spots are limited and not guaranteed.\n• Written comments must be submitted by November 21\, 2024 via the meeting's public docket on Regulations.gov [Docket No. FDA-2024-N-4085]. \nTobacco product use remains the single most preventable cause of disease\, disability and death in the United States\, and each year\, an estimated 480\,000 Americans die prematurely from smoking or from exposure to second-hand smoke. The U.S. Department of Health and Human Services (HHS) Framework to Support and Accelerate Smoking Cessation includes a stated goal to promote ongoing and innovative research in the area of cessation. The FDA and NIH’s joint October meeting is in support of these efforts\, as the Department advances our collective efforts to improve the nation’s health. \nRegister Now \n  \n  \n 
URL:https://cpdd.org/event/fda-and-nih-joint-public-meeting-on-advancing-smoking-cessation-priorities/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241021T090000
DTEND;TZID=America/New_York:20241021T163000
DTSTAMP:20260405T111038
CREATED:20241008T164930Z
LAST-MODIFIED:20241008T164930Z
UID:13698-1729501200-1729528200@cpdd.org
SUMMARY:Advancing Smoking Cessation: FDA and NIH Priorities
DESCRIPTION:Advancing Smoking Cessation: FDA and NIH Priorities \nAttend the joint public meeting hosted by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH). \nGoals and Objectives:  This public meeting will address the need for novel smoking cessation products to help individuals of all ages\, including underserved and vulnerable populations\, stop smoking. The overall goal of the meeting is to stimulate novel product development to reduce rates of smoking and related chronic illnesses. The meeting format will include presentations and panel discussions. \nIn-person Attendance Information: This meeting will be held at the FDA White Oak Campus in the Great Room. Address: 10903 New Hampshire Avenue Bldg. 31\, Room 1503\, Silver Spring\, MD 20903 \nThe FDA will make every effort to accommodate persons with physical disabilities or special needs at public meetings. If a reasonable accommodation is needed\, please indicate accordingly during registration and email TobaccoCessation@fda.hhs.gov. Requests for sign language interpretation should be made at least 7 days before the public meeting. A request for ASL services should be sent directly to the FDA Interpreting Services Staff email account: interpreting.services@fda.hhs.gov. The FDA White Oak campus and FDA shuttle are generally accessible to people with physical disabilities. \nAdditional information to assist with in-person attendance may be found within the following webpages: Public Meeting Information\, Getting to the FDA\, and Visitor Parking and Campus Map. \nVirtual Attendance Information: The Zoom link will be provided to all registered attendees before the meeting. Virtual attendees can join the meeting by computer or phone. \nInterested in submitting a request to make an oral presentation during the meeting? \nIndividuals attending the meeting in person may submit requests to make oral presentations at the public meeting. Select “In-person registration with presentation request\,” follow the instructions presented in the confirmation email\, and submit all details by 5 p.m. EDT\, October 1\, 2024. \nContact: For additional details and questions contact the meeting support team at TobaccoCessation@fda.hhs.gov. \nPlease note: In addition to this public meeting\, the public can submit electronic or written comments to the docket until November 21\, 2024\, at 11:59 p.m. Eastern Time. Please visit the Federal Register Notice for the “Advancing Smoking Cessation: FDA and NIH Priorities” for more information about submitting comments.
URL:https://cpdd.org/event/advancing-smoking-cessation-fda-and-nih-priorities/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250116T120000
DTEND;TZID=America/New_York:20250116T130000
DTSTAMP:20260405T111038
CREATED:20250102T153922Z
LAST-MODIFIED:20250106T204212Z
UID:13980-1737028800-1737032400@cpdd.org
SUMMARY:NEW DATE - FDA Grand Rounds on The PATH from Data to Action
DESCRIPTION:Join January 16 FDA Grand Rounds - The PATH from Data to Action: Key Findings from the Population Assessment of Tobacco and Health Study to Inform FDA’s Regulatory Activities \nThe Population Assessment of Tobacco and Health (PATH) Study\, a national\, longitudinal cohort study of tobacco use and health in the United States\, is one of the first large tobacco research efforts undertaken by FDA Center for Tobacco Products (CTP) and National Institute of Health (NIH) after Congress gave FDA authority to regulate tobacco products in 2009. \nThis presentation will share an overview and history of the PATH Study\, evolution of the study design made over time in response to important changes in tobacco marketplace and regulatory environment and highlight how its designs and findings can inform tobacco regulatory science and public health. \nWhen: Thursday January 16\, 2025; 12:00 p.m. - 1:00 p.m. ET \nRegister for Webinar:  https://www.fda.gov/science-research/fda-grand-rounds/fda-grand-rounds-path-data-action-key-findings-population-assessment-tobacco-and-health-path-study?utm_campaign=ctp-sos&utm_content=event&utm_medium=email&utm_source=govdelivery&utm_term=stratcomms#event-information \n  \n 
URL:https://cpdd.org/event/fda-grand-rounds-on-the-path-from-data-to-action/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250130T140000
DTEND;TZID=America/New_York:20250130T150000
DTSTAMP:20260405T111038
CREATED:20250113T194124Z
LAST-MODIFIED:20250113T194124Z
UID:14021-1738245600-1738249200@cpdd.org
SUMMARY:Demystifying Medications for Substance Use Disorder
DESCRIPTION:January 30 | Demystifying Medications for Substance Use Disorder @ 2 p.m. ET\nSave the date for this upcoming event! \nhttps://www.samhsa.gov/about/digital-toolkits/substance-use-disorder-treatment-month
URL:https://cpdd.org/event/demystifying-medications-for-substance-use-disorder/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250206T130000
DTEND;TZID=America/New_York:20250206T140000
DTSTAMP:20260405T111038
CREATED:20250115T193234Z
LAST-MODIFIED:20250115T193234Z
UID:14043-1738846800-1738850400@cpdd.org
SUMMARY:"What’s Emergent in Emerging Adult Recovery Support Services Research?" Forum Series (Part 1)
DESCRIPTION:"What’s Emergent in Emerging Adult Recovery Support Services Research?" Forum Series (Part 1) \n"Emerging adults aged 16–25 face heightened risks of opioid use disorder (OUD) and fentanyl-related overdoses. Although medications for opioid use disorder (MOUD) are effective for long-term management\, emerging adults often encounter significant challenges\, including unmet needs in employment\, housing\, and social support. These difficulties are further combined with life transitions\, such as establishing independence\, pursuing vocational growth\, and fostering stable relationships\, along with risks of high rates of co-occurring mental health issues and polysubstance use\, which can complicate recovery efforts. Despite these challenges\, very few research studies have addressed the unique recovery needs of this population. \nThis forum series offers a platform for meaningful dialogue on how to best support emerging adults in their recovery journeys. Participants will have the opportunity to learn from and collaborate with experts\, young adults with lived experience\, and researchers. Part 1 of this virtual series features a comprehensive discussion on key care principles for emerging adults' recovery\, grounded in an in-depth article review." \nTo Register:  https://www.jeapinitiative.org/ea-recovery-support-forums/ \nQuestions:  jeap@chestnut.org
URL:https://cpdd.org/event/whats-emergent-in-emerging-adult-recovery-support-services-research-forum-series-part-1/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250212T123000
DTEND;TZID=America/New_York:20250212T140000
DTSTAMP:20260405T111038
CREATED:20241230T170916Z
LAST-MODIFIED:20241230T170916Z
UID:13976-1739363400-1739368800@cpdd.org
SUMMARY:
DESCRIPTION:NABR Webinar: “The FY 2024 USDA Oversight Process”  \nPlease join us on Jan. 14\, 2025\, at 12:30 p.m. EST for the first of NABR’s 2025 Webinar series\, “The FY 2024 USDA Oversight Process.” Each year NABR obtains information from the USDA’s Animal Care Inspection System database using the Public Search Tool to review the inspection results for the previous fiscal year and provides a review and analysis of that information. The Public Search Tool was updated in September 2020 and now also contains information on enforcement actions including letters of warning and stipulation agreements. A preliminary review of the data using the Public Search Tool shows that the number of inspections conducted in FY 2024 was in line with the number conducted in FY 2023\, but the total number of noncritical\, critical and repeat citations decreased. In this webinar we will present our annual review of the inspection data along with an analysis of the type of noncompliant items cited and the enforcement actions taken as result of certain citations issued. \nRegister at this link:  https://register.gotowebinar.com/register/3774571084692246358 \n 
URL:https://cpdd.org/event/13976/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250219T120000
DTEND;TZID=America/New_York:20250219T130000
DTSTAMP:20260405T111038
CREATED:20250213T160807Z
LAST-MODIFIED:20250213T160807Z
UID:14274-1739966400-1739970000@cpdd.org
SUMMARY:Vermont Center on Behavior & Health Monthly Lecture Series
DESCRIPTION:Vermont Center on Behavior & Health Monthly Lecture Series \nMichael Amlung\, PhD\nAssociate Professor in Applied Behavioral Science at University of Kansas\nWednesday\, February 19\, 2025\, 12-1 pm\nUVMMC Davis Auditorium\nApplication of behavioral economics to investigate contextual influences on alcohol and cannabis use \nRegistration Link:  https://uvmcom.zoom.us/webinar/register/WN_nDjyfnScRCq_ZXmfEwcSyA#/registration  \nDr. Michael Amlung is an Associate Professor and Director of Graduate Studies in the Department of Applied\nBehavioral Science and Associate Director for Training and Associate Scientist in the Cofrin Logan Center for Addiction\nResearch and Treatment. He directs the Behavioral Economics and Addiction Neuroscience Laboratory\, which conducts\nresearch on causes\, consequences\, and treatment of addictive disorders. His research examines factors that contribute to\npathological decision-making in individuals with substance use disorders\, the behavioral and brain basis of motivation to\nuse alcohol and other drugs\, and the effects of environmental contexts and physiological states on addictive behaviors. His\nresearch is funded by the National Institute on Alcohol Abuse and Alcoholism\, the Canadian Institutes for Heath\nResearch\, and the University of Kansas Center for Research.
URL:https://cpdd.org/event/vermont-center-on-behavior-health-monthly-lecture-series/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250306T130000
DTEND;TZID=America/New_York:20250306T140000
DTSTAMP:20260405T111038
CREATED:20250115T193022Z
LAST-MODIFIED:20250115T193022Z
UID:14041-1741266000-1741269600@cpdd.org
SUMMARY:"What’s Emergent in Emerging Adult Recovery Support Services Research?" Forum Series (Part 2)
DESCRIPTION:"What’s Emergent in Emerging Adult Recovery Support Services Research?" Forum Series (Part 2) \n"Emerging adults aged 16–25 face heightened risks of opioid use disorder (OUD) and fentanyl-related overdoses. Although medications for opioid use disorder (MOUD) are effective for long-term management\, emerging adults often encounter significant challenges\, including unmet needs in employment\, housing\, and social support. These difficulties are further combined with life transitions\, such as establishing independence\, pursuing vocational growth\, and fostering stable relationships\, along with risks of high rates of co-occurring mental health issues and polysubstance use\, which can complicate recovery efforts. Despite these challenges\, very few research studies have addressed the unique recovery needs of this population. \nThis forum series offers a platform for meaningful dialogue on how to best support emerging adults in their recovery journeys. Participants will have the opportunity to learn from and collaborate with experts\, young adults with lived experience\, and researchers. Part 2 of this virtual series will feature a dynamic panel discussion\, with emerging adults sharing personal recovery experiences and insights." \nTo Register:  https://www.jeapinitiative.org/ea-recovery-support-forums/  \nEmail jeap@chestnut.org with questions. \n 
URL:https://cpdd.org/event/whats-emergent-in-emerging-adult-recovery-support-services-research-forum-series-part-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250410T130000
DTEND;TZID=America/New_York:20250410T140000
DTSTAMP:20260405T111038
CREATED:20250115T193450Z
LAST-MODIFIED:20250115T193450Z
UID:14045-1744290000-1744293600@cpdd.org
SUMMARY:"What’s Emergent in Emerging Adult Recovery Support Services Research?" Forum Series (Part 3)
DESCRIPTION:"What’s Emergent in Emerging Adult Recovery Support Services Research?" Forum Series (Part 3) \n"Emerging adults aged 16–25 face heightened risks of opioid use disorder (OUD) and fentanyl-related overdoses. Although medications for opioid use disorder (MOUD) are effective for long-term management\, emerging adults often encounter significant challenges\, including unmet needs in employment\, housing\, and social support. These difficulties are further combined with life transitions\, such as establishing independence\, pursuing vocational growth\, and fostering stable relationships\, along with risks of high rates of co-occurring mental health issues and polysubstance use\, which can complicate recovery efforts. Despite these challenges\, very few research studies have addressed the unique recovery needs of this population. \nThis forum series offers a platform for meaningful dialogue on how to best support emerging adults in their recovery journeys. Participants will have the opportunity to learn from and collaborate with experts\, young adults with lived experience\, and researchers. Part 3 of this virtual series features presentations by leading recovery scientists highlighting the latest research and innovative strategies for supporting emerging adults' recovery." \nTo Register:  https://www.jeapinitiative.org/ea-recovery-support-forums/ \nQuestions:  jeap@chestnut.org
URL:https://cpdd.org/event/whats-emergent-in-emerging-adult-recovery-support-services-research-forum-series-part-3/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250423T130000
DTEND;TZID=America/New_York:20250423T130000
DTSTAMP:20260405T111038
CREATED:20250310T192900Z
LAST-MODIFIED:20250310T192900Z
UID:14347-1745413200-1745413200@cpdd.org
SUMMARY:ISAJE/CPDD Publishing Addiction Science Collaborative Webinar
DESCRIPTION:ISAJE Publishing Addiction Science Collaborative Webinar \nPlease join The College on Problems of Drug Dependence (CPDD) and the International Society of Addiction Journal Editors (ISAJE) for an insightful collaborative webinar designed to help researchers navigate the complexities of academic publishing. \n\nAdam J. Gordon\, M.D.\, MPH\, FACP\, DFASAM Journal Metrics and Choosing the Right Journal Editor-in-Chief\, Substance Use & Addiction Journal \n\nEmily C. Williams\, Ph.D. Strategies for Revising and Resubmitting Papers Co-Editor-in-Chief\, Addiction Science & Clinical Practice \n\n\n\nCaravella McCuistian\, Ph.D.\, M.A. Addressing Paper Rejections and Next Steps Editor-in-Chief\, Journal of Psychoactive Drugs \n\nAnees Bahji\, Ph.D. Maximizing Impact After Publication Assistant Editor\, Canadian Journal of Addiction \n\nBryon Adinoff\, M.D. Moderator Editor-in-Chief\, American Journal of Drug and Alcohol Abuse \n\nCasy Calver\, Ph.D.\, MSc. Moderator Executive Officer\, ISAJE & Editorial Director\, Grayken Center for Addiction at Boston Medical Center \n\n\n\n\nUse this link to register: https://us02web.zoom.us/webinar/register/WN_Wt6LCM_OTzuVX6GvbInINw?_gl=1*1lwsq9s*_gcl_au*MTczMjAxMTQ0OC4xNzM4NzA2OTA2*_ga*MjA3MzM0ODYwLjE3NDAxNjMzNjE.*_ga_L8TBF28DDX*MTc0MDUwODk4MC41LjEuMTc0MDUwOTYxMS4wLjAuMA..#/registration 
URL:https://cpdd.org/event/isaje-cpdd-publishing-addiction-science-collaborative-webinar/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250525T080000
DTEND;TZID=America/New_York:20250525T170000
DTSTAMP:20260405T111038
CREATED:20241014T212044Z
LAST-MODIFIED:20241014T212044Z
UID:13722-1748160000-1748192400@cpdd.org
SUMMARY:ISAM Annual Congress - Hamburg\, Germany - May 25\, 2025
DESCRIPTION:Global Innovation Day for Addiction Therapeutics \nAddiction is a major public health issue affecting millions worldwide. Innovative solutions are urgently needed to combat this crisis\, reduce its impact\, and save lives. The World Innovation Day for Addiction Therapeutics serves as a platform for fostering collaboration between academia\, health sector\, regulatory agencies\, and industry\, driving innovation\, and accelerating the development of effective tools and technologies for assessment and treatments for addiction and its comorbidities. By bringing together experts from various fields\, this event aims to catalyze the development of new modalities for assessment\, therapies\, and interventions. There are several reasons why convening such an event matters: \nBridging the Gap: There is often a disconnection between scientific discoveries and their implementation in real-world settings. This event aims to bridge that gap by facilitating dialogue and collaboration between clinicians from the addiction medicine/psychiatry academia\, industry professionals\, and researchers from both\, facilitating the translation of groundbreaking research into tangible benefits for patients. \nEnhancing Investment: Securing funding is a significant hurdle in the journey from research to market. The presence of senior venture capital and other types of investors and funding agencies at this event provides a unique opportunity for startups and established companies to showcase their innovations\, attract investment\, and accelerate their growth. \nKnowledge Sharing: The event will feature multiple panels and lectures\, offering participants a chance to share their experiences\, learn from each other\, and stay updated on the latest trends and advancements in the field of addiction medicine therapeutics. This exchange of knowledge is crucial for driving progress and fostering a collaborative environment. \nBuilding a Stronger Community: By gathering many leaders from clinics\, universities\, industry\, regulatory agencies and investment communities\, this event creates a robust network of professionals committed to improving addiction treatment. These connections can lead to long-term collaborations\, innovative projects\, and a stronger\, more unified approach to addressing addiction. \nThe First World Innovation Day for Addiction Therapeutics will be on May 25th\, in Hamburg\, Germany as a full day pre-conference event for the ISAM 2025 Annual Congress \nhttps://www.isam-hamburg.com/ \n\n\nWho is Invited?  We would like to invite all companies\, startups\, and entrepreneurs active in developing products for addiction prevention\, assessment\, treatment\, and rehabilitation to join us for “World Innovations for Addiction Therapeutics – From Scientific Discovery to Saving Lives.” This is an ISAM event designed for academia/industry partnership\, focusing on innovation and investment in newest technologies for helping patients affected by addictions and their comorbidities. This event will take place on Sunday\, May 25\, 2025\, in Hamburg\, Germany\, as part of the official pre-conference activities of the ISAM 27th Global Congress. Bringing together more than many leaders from clinics\, universities\, industry\, and investment communities\, this unique gathering aims to facilitate the exchange of experiences and visions for this evolving field. \nAt ISAM’s Innovations Day\, both innovators and established companies will have the opportunity to share their ideas\, product and company narratives with clinicians\, scientists\, venture capitalists\, engineers\, regulatory agencies\, and industry professionals. Aligned with the theme of the day\, participating companies are invited to spotlight the challenges and advantages of innovation specific to their products from discovery to implementation in communities. The agenda for the day will include multiple panels and talks\, ensuring that all the registered\, invited and willing participants have the opportunity for podium time\, either individually or as part of panel discussions. \nIn addition to the presenting companies\, senior venture capital investors from major corporations will be invited. This offers an excellent platform for you and your company to showcase your vision\, ideas\, achievements\, forge new connections\, learn from peers\, assess progress\, and become more competitive and successful in the future market of addiction therapeutics. \nThe Application Process:  We encourage all companies\, startups\, and entrepreneurs active in developing products for addiction prevention\, assessment\, treatment\, and rehabilitation to consider participating in this event. If you are interested\, please submit your letter of interest by sending an email to the ISAM office isam.mdorozio@gmail.com to join the event at your earliest convenience. The subject line of email should be “Expressing Interest in ISAM 2025 Innovation Day.” Subsequently\, you will hear from us. \nPlease note that the established companies selected to participate will enter into an agreement with the ISAM through which the responsibilities / liabilities / entitlements of each of the parties shall be articulated and agreed upon. Please also note that each company selected to participate will\, as a part of the agreement with ISAM\, provide an unrestricted grant to the ISAM\, a 501(c)3 nonprofit organization registered in Canada\, besides paying the registration fee for the ISAM 2025 conference. \nThe Agenda Outline (TBC)\nA. Morning Sessions \n– 07:00 – 8:30: Registration\, and networking \n– 8:30 – 8:45: Welcome and Introduction\, Chair and Scientific Director \n– 08:45 – 09:00: Opening Talk: Urgent Needs for Innovations in Addiction Therapeutics in the Global Level\, Anja Busse (UNODC) and Dzmitry Krupchanka (WHO) \n– 09:00 – 09:30: Lecture 1: Innovations in Addiction Therapeutics\, Ivan Motoya\, Director\, Division of Therapeutics and Medical Consequences at US National Institute on Drug Abuse (NIDA) \n– 09:30 – 10:00: Lecture 2: Regulatory Considerations in Development of Therapeutics: From Discovery to Market\, European and US Perspective\, EMA Representative and FDA Representative \n– 10:00 – 10:45: Companies and Startups Panel I: Preclinical Advances in Novel Molecular\, Cellular and Circuit-based Targets for Addiction Therapeutics (3-4 companies) \n– 10:45 – 11:15: Break \n– 11:15 – 11:45: Lecture 3: How Brain Mapping Can Inform New Generation of Circuit-based Addiction Treatment \n– 11:45 – 12:30: Companies and Startups Panel II: Neuromodulation for Addiction Therapeutics (3-4 companies) \n– 12:30 – 13:30: Lunch Break \nB. Afternoon Sessions \n– 13:30 – 14:00: Lecture 4: How Mobile Apps and Telemedicine Can Reshape the Future of Addiction Treatment? \n– 14:00 – 14:45: Companies and Startups Panel III: Digital and Behavioral Therapeutics (3-4 companies) \n– 14:45 – 15:30: Companies and Startups Panel IV: From Early Clinical to Ready to Launch Products (3-4 companies) \n– 15:30 – 16:00: Lecture 5: Global Governments and International Organizations Panel: WHO\, UNODC\, USA (NIDA)\, Europe (EUDA)\, UK\, Japan\, Brazil\, Australia \n– 16:00 – 16:30: Discussion Panel: Feedbacks from Addiction Clinicians and People with Lived or Living Experience in Drug Use: Most Promising Innovations in Addiction Therapeutics \n– 16:30 – 17:00: Closing Remarks \n– 19:00 – 21:00: Informal Social and Networking Dinner and Bar (out of pocket unless we will find a sponsor) \nThis meeting will be a pre-conference event with many opportunities for further discussions and networking meetings during 3 days of ISAM2025 conference. \nOrganizing Team\nChair: ISAM President\, Hamed AlGhaferi\nScientific Director: Hamed Ekhtiari\nLeadership Team: Marc Potenza\, Alexander Balddachino\, Yasse Khazaal\, Tarek Gawad\, Susanna Galea-Singer\, Atul Ambekar\nAdvisory Board: Ivan Montoya (NIDA)\, Anja Busse (UNODC)\, Marica Ferri (EUDA)\, Dzmitry Krupchanka (WHO)\, Anne Lingford-Hughes (Addiction Mission\, UK)\nCompliance Officer: Roshan Bhad\nISAM Officer: Marilyn Dorozio\nExecutive Team: Philip Hillier (ISAM2025)\, Mary Janssen van Raay (ISAM2026)\, Yasser Gawad\, Mehran Zare-Bidoky\, Arash Zonoozi\, Mehmet Serhat Yildirim\, Fateme-Sadat Abolghasemi\, Başak Ünübol\, Ediz Eyüpoğlu\, Jenna Butner
URL:https://cpdd.org/event/isam-annual-congress-hamburg-germany-may-25-2025/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250529T120000
DTEND;TZID=America/New_York:20250529T120000
DTSTAMP:20260405T111038
CREATED:20250521T134518Z
LAST-MODIFIED:20250521T134518Z
UID:14660-1748520000-1748520000@cpdd.org
SUMMARY:Register Today: Civic Engagement Alliance Discussion
DESCRIPTION:Register Today: Civic Engagement Alliance Discussion \nCurious about the roles that early career researchers are playing in shaping civic science? Join us on Thursday\, May 29\, at noon ET for an Alliance Discussion featuring awardees from Research!America’s Civic Engagement Microgrant Program and Public Engagement Training Content Microgrant Program.  \nRegister on Zoom  \nNow in its 7th year\, our Civic Science Microgrant initiative has supported nearly 150 creative\, student-led projects across the country. These efforts empower STEM graduate students\, professional students\, and postdocs to tackle challenges at the intersection of science and society and connect directly with local officials\, community leaders\, and non-scientists to drive meaningful engagement with the public. We are also exploring new approaches to developing the skills scientists need to undertake this work.  \nThree awardees will share their experiences as part of the two programs. \nAshley Lauterbach\, Belmont University \n“Pharmacy Advocacy Initiative: Preparing Voices of Change” - a project that highlights the role of pharmacists beyond the counter as change agents for healthcare advocacy.  \nJustine Silva\, University of California\, Irvine \nA digital training initiative that equips medical professionals to engage thoughtfully with brain donor families. \nDr. Myesha Shelby\, Howard University \n“Interfaith Dialogues: Building Science Perspectives” - facilitated conversations between scientists and faith-based communities on the importance of scientific research.  \nDr. Fanuel Muindi\, Professor of the Practice\, Civic Science Journalism\, Northeastern University; Founder & Director\, Civic Science Media Lab\, will join as a discussant. \nBring your questions and join us for an exciting discussion with scientists who are working to build important connections outside of their university walls.  \nWe thank our funders: HHMI\, the Lasker Foundation\, the Dana Foundation\, and Dennis Mangan. \nI hope you will join us! \nJenny \nJennifer Luray\nSenior Vice President\, Strategy and Public Engagement\nResearch!America\nFollow us on social media \nReceive Mary Woolley’s Weekly Letter \n 
URL:https://cpdd.org/event/register-today-civic-engagement-alliance-discussion/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250722T123000
DTEND;TZID=America/New_York:20250722T133000
DTSTAMP:20260405T111038
CREATED:20250625T144043Z
LAST-MODIFIED:20250625T144043Z
UID:14765-1753187400-1753191000@cpdd.org
SUMMARY:NABR Webinar: Q&A With the USDA - The 13th Edition - Animal Care’s Animal Welfare
DESCRIPTION:June 18\, 2025\nNABR Webinar: Q&A With the USDA - The 13th Edition \n​​​​NABR is once again pleased to announce the return of one of its most requested webinars\,  "Q&A with the USDA." Join USDA-APHIS Animal Care’s Dr. Louis DiVincenti\,  Acting Director of Animal Welfare Operations\, for "Q&A with the USDA: The Thirteenth Edition” on Tuesday\, July 22th at 12:30 p.m. EDST and meet Sarah Helming\, Deputy Administrator of APHIS Animal Care. As in the past\, this webinar will provide NABR members with a unique opportunity to ask questions directly of the leadership of Animal Care’s Animal Welfare Operations. Since things within the federal government seem to be changing on nearly a daily basis\, this announcement will be revised as we learn of changes\, if any\, to APHIS Animal Care. You should take advantage of this unique opportunity provided to NABR members to better understand what impact these changes may have on your institution concerning compliance with the Animal Welfare Regulations.  \nQuestions should be submitted in advance to info@nabr.org. They will be reviewed and formatted to prevent duplication and will be answered in the order they are received\, so please submit them as soon as possible.  \nAs in the past we will schedule the session for an hour but will continue the webinar until all questions have been addressed. \nREGISTER HERE
URL:https://cpdd.org/event/nabr-webinar-qa-with-the-usda-the-13th-edition-animal-cares-animal-welfare/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250918T120000
DTEND;TZID=America/New_York:20250918T130000
DTSTAMP:20260405T111038
CREATED:20250904T143738Z
LAST-MODIFIED:20250904T143738Z
UID:15075-1758196800-1758200400@cpdd.org
SUMMARY:NIDA International - Publishing Addiction Science Webinar
DESCRIPTION:Publishing Addiction Science Webinar\nThursday\, September 18\, 2025\n12:00 to 1:00 p.m. Eastern Time (U.S.) \nThe NIDA International Program (IP) and the International Society of Addiction Journal Editors (ISAJE) are pleased to announce a live webinar on a topic regularly featured at the annual NIDA International Forum. The NIDA IP and ISAJE will co-host a webinar on September 18 titled “Publishing Addiction Science.” This webinar will be an insightful\, interactive presentation designed to assist researchers moving through the complex journey of academic publishing. \nThis free webinar will be held virtually\, using the Microsoft Teams platform. Attendees can participate using the Microsoft Teams desktop app or a web browser. Registration is not required. \nJoin us on September 18 at 12:00 to 1:00 p.m. (U.S.) using the Webinar Link. \nAbout the Presenters: \nCasy Calver\, Ph.D.\, M.Sc.\, is the Executive Officer for ISAJE. Dr. Calver is also the Managing Editor of Addiction Science & Clinical Practice and Editorial Director in the Clinical Addiction Research and Education Unit and the Grayken Center for Addiction at Boston Medical Center. Her doctoral dissertation in Editorial Studies was an annotated edition of the 1937 publication\, Authors Take Sides on the Spanish War. She holds an M.Sc. in Global Health Policy. \nAdam J. Gordon\, M.D.\, M.P.H.\, FACP\, DFASAM is an ISAJE board member with a 25+ year history of conducting research and has authored more than 350 peer-reviewed articles and hundreds of scholarly presentations and abstracts. Dr. Gordon is the Elbert F. and Marie Christensen Endowed Research Professor\, tenured Professor of Medicine and Psychiatry\, at the University of Utah School of Medicine and the Section Chief of Addiction Medicine at the U.S. Department of Veterans Affairs (VA) Salt Lake City Health Care System. He founded and is the Director of the Program for Addiction Research\, Clinical Care\, Knowledge\, and Advocacy and is the Director of the Greater Intermountain Node of the NIDA Clinical Trials Network. He is the Editor-in-Chief of Substance Use & Addiction Journal. \nPlease plan to join the webinar 5 minutes early to prevent any technical delays\, as this is a new webinar format being used by NIDA. \n 
URL:https://cpdd.org/event/nida-international-publishing-addiction-science-webinar/
CATEGORIES:CPDD Webinars
END:VEVENT
END:VCALENDAR